欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Metabolism > SR-3029

浏览历史

S83404

SR-3029

源叶(MedMol) 98%
  • 英文名:
  • SR-3029
  • 别名:
  • CAS号:
  • 1454585-06-8
  • 分子式:
  • C23H19F3N8O
  • 分子量:
  • 480.4452
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S83404-2mg 98% ¥180.00元 5 - - - EA 加入购物车
源叶(MedMol) S83404-5mg 98% ¥235.00元 6 - - - EA 加入购物车
源叶(MedMol) S83404-10mg 98% ¥420.00元 6 - - - EA 加入购物车
源叶(MedMol) S83404-25mg 98% ¥980.00元 6 - - - EA 加入购物车
源叶(MedMol) S83404-50mg 98% ¥1640.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: SR-3029 is a potent and ATP competitive CK1δ and CK1ε inhibitor, with IC50s of 44 nM and 260 nM, respectively, and Kis of 97 nM for both kinases.
  • 靶点: CKIδ:44 nM (IC50);CDK6/cyclin D3:427 nM (IC50);CDK6/cyclin D1:428 nM (IC50);CDK4/cyclin D3:368 nM (IC50);CDK4/cyclin D1:576 nM (IC50);FLT3:3000 nM (IC50);CaseinKinase
  • 体外研究:
    SR-3029 is a potent CK1δ/CK1ε inhibitor, with IC50s of 44 nM and 260 nM, respectively. SR-3029 is ATP competitive, with Kis of 97 nM for CK1δ/CK1ε. SR-3029 also blocks CDK6/cyclin D3, CDK6/cyclin D1, CDK4/cyclin D3, CDK4/cyclin D1 and FLT3, with IC50s of 427, 428, 368, 576, and 3000 nM, respectively. SR-3029 shows inhibitory effects on A375 cells, with an EC50 of 86 nM. CK1δ is a necessary and sufficient driver of Wnt/β-catenin signaling in human breast cancer. SR-3029 shows less potent activities against MCF7 and T47D breast cancer cells and the MCF10A cell line, which express low amounts of CK1δ
  • 体内研究:
    SR-3029 (20 mg/kg daily i.p.) exibits anti-tumor effects in rthotopic MDA-MB-231, MDA-MB-468 (TNBC), SKBR3 and BT474 (HER2+) tumor xenografts with no overt toxicity in mice. SR-3029 (20 mg/kg daily i.p.) also effectively inhibits the growth of tumor in primary patient-derived xenograft (PDX) models. In addition, SR-3029 (20 mg/kg, i.p.) strongly reduces the expression of nuclear β-catenin in tumors of mice
  • 参考文献:
    1. Bibian M, et al. Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties. Bioorg Med Chem Lett. 2013 Aug 1;23(15):4374-80. 2. Rosenberg LH, et al. Therapeutic targeting of casein kinase 1δ in breast cancer. Sci Transl Med. 2015 Dec 16;7(318):318ra202.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.081 ml 10.407 ml 20.814 ml
    5 mM 0.416 ml 2.081 ml 4.163 ml
    10 mM 0.208 ml 1.041 ml 2.081 ml
    50 mM 0.042 ml 0.208 ml 0.416 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。